Announcement

Collapse
No announcement yet.

Optimization of 4-aminopiperidines as inhibitors of influenza A viral entry that are synergistic with oseltamivir

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Optimization of 4-aminopiperidines as inhibitors of influenza A viral entry that are synergistic with oseltamivir


    J Med Chem. 2020 Feb 18. doi: 10.1021/acs.jmedchem.9b01900. [Epub ahead of print] Optimization of 4-aminopiperidines as inhibitors of influenza A viral entry that are synergistic with oseltamivir.

    Gaisina IN, Peet N, Cheng H, Li P, Du R, Cui Q, Furlong K, Manicassamy B, Caffrey M, Thatcher GR, Rong L.
    Abstract

    Vaccination is the most prevalent prophylactic means for controlling seasonal influenza infections. However, an effective vaccine usually takes at least 6 months to develop for the circulating strains. Therefore, new therapeutic options are needed for the acute treatment of influenza infections to control this virus and prevent epidemics/pandemics from developing. We have discovered fast-acting, orally bioavailable acylated 4-aminopiperidines with an effective mechanism of action targeting viral hemagglutinin (HA). Our data show that these compounds are potent entry inhibitors of influenza A viruses. We present docking studies that suggest an HA binding site for these inhibitors on H5N1. Compound 16 displayed a significant decrease of viral titer when evaluated in the infectious assays with influenza virus H1N1 (A/PuertoRico/8/1934) or H5N1 (A/Vietnam/1203/2004) strains and the oseltamivir-resistant strain with the most common H274Y mutation. In addition, compound 16 showed significant synergistic activity with oseltamivir in vitro.


    PMID: 32069052 DOI: 10.1021/acs.jmedchem.9b01900

Working...
X